AKT1 and cancer: AKT-inhibited cancer cells activate their endomembrane system in a posttranscriptional manner to secrete inflammatory proteins IL-6 and IL-8, and extracellular vesicles (EVs), which enable rapidly growing cells to better withstand the stress conditions induced by drug treatment.